CMFRI develops seaweed-based product to fight non-alcoholic fatty liver The Hindu dated 21st December 2022

CMFRI, Library (2022) CMFRI develops seaweed-based product to fight non-alcoholic fatty liver The Hindu dated 21st December 2022. The HIndu.

Preview

Text The Hindu_ 21-12-2022.pdf Download (164kB) | Preview

Abstract

The CMFRI signed a memorandum of understanding (MoU) with Emineotech, a private limited company dealing with health products, for commercial production and marketing of patent-protected Nutraceutical developed by the ICAR-Central Marine Fisheries Research Institute (CMFRI) from seaweeds to combat non-alcoholic fatty liver disease (NAFLD). Dr.Gopalakrishnan, Director of CMFRI signed a licence agreement with Evanjalist Pathrose, managing director of Emineotech.

Item Type:	Article
Subjects:	CMFRI News Clippings
Divisions:	CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division Subject Area > CMFRI > CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division Subject Area > CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division
Depositing User:	Mr. Augustine Sipson N A
Date Deposited:	26 Dec 2022 04:41
Last Modified:	26 Dec 2022 04:41
URI:	http://eprints.cmfri.org.in/id/eprint/16547

Actions (login required)

View Item